Edition:
United States

Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

28.15USD
4:00pm EDT
Change (% chg)

$0.33 (+1.19%)
Prev Close
$27.82
Open
$27.61
Day's High
$28.96
Day's Low
$27.61
Volume
32,734
Avg. Vol
68,971
52-wk High
$35.79
52-wk Low
$20.08

GHDX.OQ

Chart for GHDX.OQ

About

Genomic Health, Inc. is a healthcare company, which provides genomic-based diagnostic tests for the treatment of early stage cancer. The Company offers its Oncotype DX tests as a clinical laboratory service, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a quantitative gene... (more)

Overall

Beta: 0.48
Market Cap(Mil.): $918.48
Shares Outstanding(Mil.): 33.02
Dividend: --
Yield (%): --

Financials

  GHDX.OQ Industry Sector
P/E (TTM): -- 41.28 37.71
EPS (TTM): -0.93 -- --
ROI: -20.13 -9.20 14.43
ROE: -20.51 -9.24 15.61

BRIEF-Genomic Health increased number of board members on June 21

* On June 21, 2016 board increased the authorized number of members of the board of directors of the company to eight Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 23 2016

BRIEF-Genomic Health reports Q1 loss per share of $0.19

* Reports double-digit revenue and test growth in announcement of first quarter 2016 financial results

May 04 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.